Groundwater is the principal source of drinking water for 14--15 million (14%) of the 105.5 million homes in the United States and for approximately 42 million people \[[@b18-ehp0115-001237]; [@b45-ehp0115-001237]; [@b49-ehp0115-001237]\].

Groundwater is at risk of contamination by a wide variety of industrial pollutants and naturally occurring toxic chemicals. Industrial chemicals that have been identified in ground-water include benzene, methyl *tert*-butyl ether, nickel, perchlorate, perchloroethylene, pesticides, phenol, and trichloroethylene \[[@b3-ehp0115-001237], [@b4-ehp0115-001237], [@b5-ehp0115-001237], [@b6-ehp0115-001237], [@b9-ehp0115-001237], [@b10-ehp0115-001237]; [@b13-ehp0115-001237]; [@b49-ehp0115-001237]\]. These contaminants are most commonly found near chemical and pesticide production facilities, hazardous waste sites, roads, and railways. Naturally occurring toxic chemicals that have been documented in groundwater include arsenic, manganese, radon, and uranium ([@b7-ehp0115-001237], [@b8-ehp0115-001237];[@b49-ehp0115-001237]). These materials may be present in especially high concentrations in mining districts, but also occur widely in certain geologic formations, especially in mountainous areas of the United States ([@b49-ehp0115-001237]; [@b50-ehp0115-001237]).

Private wells that tap groundwater have been associated with episodes of human exposure to toxic chemicals ([@b49-ehp0115-001237]). Private wells in the United States are largely exempt from state and federal drinking water regulations, and thus in most states they are not subject to much of the mandatory testing that is required of public water supplies under the provisions of the [@b39-ehp0115-001237]. In most locations, well water is routinely tested only for pH, bacteria, and a small number of chemical contaminants. Uranium is not commonly among the chemicals tested. Because of increasing urban sprawl with continuing movement of populations from urban centers to previously rural areas that lack public water supplies ([@b23-ehp0115-001237]), a growing number of private wells are being drilled in the United States. Unless changes are mandated in current testing requirements, the number of people at risk of exposure to toxic chemicals in groundwater will therefore likely increase.

Exposures to chemical contaminants in groundwater have caused disease and disability in exposed populations. The prevalence and severity of these effects reflect the intensity, the duration, and the developmental timing of exposure. Reported health effects have included diminished intelligence after prenatal exposures to lead and manganese; peripheral vascular disease and skin cancer after childhood exposure to arsenic; and fatal methemoglobinemia after exposure in infancy to nitrates ([@b1-ehp0115-001237]; [@b17-ehp0115-001237]; [@b36-ehp0115-001237]).

Infants and young children are especially vulnerable to chemical contaminants in drinking water. This heightened vulnerability reflects the disproportionately great water consumption of young children, who drink 7 times as much water per kilogram body weight per day as the average adult ([@b21-ehp0115-001237]) ([Figure 1](#f1-ehp0115-001237){ref-type="fig"}). It also reflects the inherent biological vulnerability of the young, which is a consequence of their rapid growth and development and their relative inability to detoxify and excrete many exogenous chemicals \[[@b34-ehp0115-001237]\].

We present a case of a family who was exposed to naturally occurring uranium in groundwater from their private well in Connecticut. Although all family members had evidence of exposure, the only family member with evidence of nephrotoxicity was the youngest child.

Case Presentation
=================

In September 2000 a family of seven---two adults and five children 3, 5, 7, 9, and 12 years of age---living in a development in rural northwestern Connecticut discovered highly elevated levels of uranium in the drinking water of the home where they had resided for 5 years. The home water was supplied by a private well that tapped groundwater at a depth of approximately 500 feet. The family had used water from this well for cooking, drinking, and bathing from the time that they had moved into the home until discovery of the contamination.

The family first became aware of the possibility of uranium exposure after a neighbor was found to have markedly elevated levels of uranium in her hair. This neighbor had had her hair tested for a range of metals because she was concerned that she had been exposed to mercury from her dental fillings; mercury levels in the neighbor's hair were not elevated.

After the discovery of elevated levels of uranium in her hair, the neighbor had the water from her well tested for uranium. Her well water was found to contain uranium at a level of 41 pCi/L. Applying the U.S. EPA conversion factor of 0.9 pCi/μg (an estimate based on the ratio of uranium species found typically by the U.S. EPA in well water) this translates to 46 μg/L, a value above the U.S. EPA maximum contaminant level (MCL) for uranium in public water supplies of 30 μg/L ([@b47-ehp0115-001237]). In response to their neighbor's discovery of uranium in her well water, the index family had their well water tested. Initial testing in a private laboratory (RSA Laboratories, Inc., Hebron, CT) on 28 September 2000 returned a level of 866 μg/L (779 pCi/L), a value also above the U.S. EPA MCL. Repeat measurement by the State of Connecticut Department of Public Health Laboratory (Hartford, CT) on 12 October 2000 returned a level of 1,160 μg/L (1049 pCi/L). Investigation for other contaminants revealed that arsenic was present at a concentration of 0.104 mg/L (above the current U.S. EPA MCL of 0.01 mg/L) ([@b48-ehp0115-001237]) and radium 226 and 228 combined activity was measured at 15.61 pCi/L (above the U.S. EPA MCL for combined activity of 5 pCi/L). The family was advised to immediately stop consuming water from their home well.

Environmental assessment
------------------------

Environmental investigation was undertaken by the State of Connecticut Department of Public Health (Hartford, CT). Agency staff collected samples from the index family, as described above, and from other nearby homes in the development where the family resided. The State of Connecticut Department of Public Health Laboratory analyzed the water samples for uranium and radon and air samples for radon.

Environmental assessment revealed that four of 11 homes tested in the development where the index family resided had elevated levels of uranium in their well water. The level of uranium contaminations was quite variable, with very high levels occurring in some homes and almost none in adjoining homes ([Table 1](#t1-ehp0115-001237){ref-type="table"}).

Geologic assessment by the Connecticut Department of Public Health determined that this housing development had been built in the Appalachian foothills of northern Connecticut and that it sat above the "Brookfield Gneiss," a metamorphic rock formation common throughout the Appalachian ridges of western New England. Geologic formations similar to the Brookfield Gneiss have been shown to contain concentrated pockets of natural uranium ([@b38-ehp0115-001237]; [@b50-ehp0115-001237]). The Connecticut Department of Public Health considered naturally occurring metals in the Brookfield Gneiss to be the most likely source of the uranium and other minerals detected in the index family's well water. Review of town and county records and of business directories revealed no evidence of any current or past metal mining or other industrial source of uranium or other toxic metals in the area.

Clinical assessment
-------------------

To assess the uranium exposure of family members, a 24-hr measurement of urine uranium was obtained by a pediatric nephrologist in our group (L.S.) from all family members in October 2000, 4 weeks after cessation of well water consumption, an event that had occurred on 28 September 2000 ([Table 2](#t2-ehp0115-001237){ref-type="table"}). An additional 24-hr collection was obtained from the parents in November 2000, 6 weeks after cessation of well water consumption. At least one urine uranium measurement was found to be elevated in six of the seven family members. Levels ranged from \< 1 μg/L to 6.2 μg/L, well above the mean concentration in the U.S. population of 0.009 μg/L ([@b19-ehp0115-001237]). When adjusted for urinary volume, uranium excretion was 1.1--2.5 μg uranium/24 hr (values above the \< 1 μg uranium/24 hr expected in an unexposed population). Although elevated levels of radon, radium, and arsenic were found in the family's water, biological measures were not pursued because these substances are not known to have chemical nephrotoxic effects. The MCLs for these substances are designed to protect against the elevated risk of cancer that exposure confers.

To assess the possible occurrence of renal tubular injury, measurements were made (by L.S.) in family members of urine beta-2-microglobulin levels ([Table 2](#t2-ehp0115-001237){ref-type="table"}). Beta-2-microglobulin is a low-molecular-weight (11.8 kD) protein that is freely filtered at the glomerulus and avidly taken up and catabolized by the proximal tubule ([@b16-ehp0115-001237]). Elevation of urine beta-2-microglobulin is a nonspecific marker of proximal tubule damage. Elevated beta-2-microglobulin levels (normal reference range in adults is \< 120 μg/L) were found in five of the seven family members and ranged from 89 to 530 μg/L, thus suggesting the possible presence of proximal tubular injury. To adjust the beta-2-microglobulin for urine volume and body mass in children, a urinary beta-2-microglobulin excretion rate (micrograms beta-2-microglobulin per gram creatinine) is commonly calculated ([@b44-ehp0115-001237]). The beta-2-microglobulin excretion rate was normal (\< 40 μg/mmol creatinine) in all family members except for the youngest child. In this 3-year-old, who unlike other family members had spent virtually all of her life in the house, the urinary beta-2-microglobulin excretion rate was 90 μg/mmol creatinine, a value more than twice the reported upper limit of normal. Three months after the family had ceased consuming water from the home well (January 2001), this child's urinary beta-2-microglobulin excretion rate had fallen to 52 μg/mmol creatinine. There was no evidence of other proximal tubule dysfunction, as evidenced (in January 2001) by the absence of glucosuria, phosphate wasting (with normal values for the tubular reabsorption of phosphate), bicarbonate wasting, or metabolic acidosis ([Table 3](#t3-ehp0115-001237){ref-type="table"}).

Analytic methods for key environmental and biological tests are reported in [Table 4](#t4-ehp0115-001237){ref-type="table"}.

Discussion
==========

This case underscores the potential hazards of consuming groundwater from private wells. It emphasizes the need to test drinking water for a wide range of potential contaminants. Specifically, it documents the potential for significant residential exposure to naturally occurring uranium in well water. The case also highlights the special sensitivity of young children to environmental exposures in the home---a reflection of the large amount of time young children spend in their homes, their developmental immaturity, and the large volume of water they consume relative to their body mass.

Uranium is a commonly occurring radioactive mineral. It is found naturally in geologic formations such as the Brookfield Gneiss. In the formation of metamorphic rock, uranium is distributed very unevenly. It typically deposits in areas of low pressure and irregular cracks. Therefore, concentrations can vary significantly within a small area. The level of uranium that appears in drinking water depends on the flow of water through complicated fracture networks within the rock, as well as on the pH, calcium content and other characteristics of groundwater. For these reasons, concentrations of uranium in closely adjoining wells may be quite different, as was seen in this case. This pattern of significant local variability in concentrations of uranium has been observed in various locations across North America ([@b35-ehp0115-001237]). Given the unpredictability of uranium concentrations in at-risk areas, testing of well water for the presence of uranium at the time of drilling a new well or the sale or transfer of a property with an existing well is a reasonable measure ([@b7-ehp0115-001237]).

Uranium can enter the body via inhalation as well as through consumption of contaminated food or water ([@b33-ehp0115-001237]). Dermal absorption is seen principally in the instance of military veterans who have been exposed to munitions containing depleted uranium and suffered puncture wounds ([@b14-ehp0115-001237]). Ingested uranium is absorbed from the digestive tract and appears initially in the blood, bound to red blood cells. Most is excreted via urine and feces, and experimental studies in humans have shown that about two-thirds of an injected dose of uranium is excreted within the first 24 hr and 75% within 5 days ([@b42-ehp0115-001237]). Retained uranium accumulates initially in the kidneys and liver and then in the skeleton ([@b32-ehp0115-001237]). Approximately 50--60% of stored uranium in the human body is found in the skeleton ([@b22-ehp0115-001237]). The biological half-life of uranium in the skeleton is approximately 300 days. The amount of uranium present in skeletal tissue is proportional to cumulative absorption ([@b27-ehp0115-001237]).

Uranium has the potential to be both chemically and radiologically toxic, but of principal concern in the context of ground-water exposure are the chemical toxic effects of uranium on the kidneys. The most extensive data on the human toxicity of uranium come from studies conducted on workers occupationally exposed in the nuclear industries ([@b43-ehp0115-001237]); these studies demonstrated increased excretion of beta-2-microglobulin with increasing duration of exposure to uranium. Investigations of Gulf War veterans exposed to depleted uranium did not find clinically significant abnormalities in renal function, but did demonstrate that mean concentrations of microalbumin were significantly elevated in the group exposed to high levels of uranium ([@b26-ehp0115-001237]; [@b41-ehp0115-001237]). There is also evidence that uranium may cause toxic effects in bone ([@b31-ehp0115-001237]).

Within the kidneys, the proximal tubules are the structures principally damaged by uranium ([@b33-ehp0115-001237]; [@b51-ehp0115-001237]). There is no evidence for glomerular injury ([@b29-ehp0115-001237]). Evidence for dose-related proximal tubular injury has been observed after both ingestion and injection of uranium in animal ([@b20-ehp0115-001237]; [@b24-ehp0115-001237]) as well as in human ([@b51-ehp0115-001237]) studies. The histopathologic damage to the proximal tubules is manifest as cytoplasmic vacuolation, interstitial scarring, and destruction of the basal lamina ([@b24-ehp0115-001237]).

The pathophysiologic consequences of the proximal tubular injury associated with exposure to uranium include decreased ability to reabsorb water and small molecules, as is evidenced by the presence of elevated levels of the low-molecular-weight protein beta-2-microglobulin in the urine ([@b29-ehp0115-001237]; [@b33-ehp0115-001237]; [@b51-ehp0115-001237];). Another marker for proximal tubule damage---increased fractional excretion of calcium and phosphate---has been observed to increase in dose-related manner after chronic ingestion of water containing uranium; this change has been observed in the absence of any increase in urinary beta-2-microglobulin to creatinine ratio ([@b29-ehp0115-001237]). There appears to be no clear threshold for these pathophysiologic changes, and they typically become evident before any histopathologic evidence of injury is manifest ([@b29-ehp0115-001237]). The severity of the tubular injury caused by uranium exposure has been shown in rat experiments involving relatively high-dose exposures to range from mild proximal tubular dysfunction to tubular necrosis ([@b25-ehp0115-001237]).

Although specific studies on the nephrotoxic effects of uranium in children have not been conducted, it is reasonable to assume that children would be at increased risk for adverse effects from exposure compared with adults. Children consume more water and food per kilogram of body weight than do adults ([Figure 1](#f1-ehp0115-001237){ref-type="fig"}) ([@b21-ehp0115-001237]; [@b34-ehp0115-001237]). Thus children will ingest proportionately greater quantities of any contaminants that are present in the water or food that they consume. For example, the 3-year-old girl in this case series who manifested elevated urinary excretion of beta-2-microglobulin was reported to derive a major portion of her nutritional intake from infant formula that was prepared by mixing powdered formula with contaminated well water.

Terminal differentiation and maturation of the kidneys and other organ systems occur postnatally, and these developing organs are especially vulnerable to the effects of toxic chemical exposures ([@b34-ehp0115-001237]). Recent studies suggest that chronic uranium exposure is associated with increases in blood pressure ([@b30-ehp0115-001237]). The long-term significance of these changes is unclear. However, children's long future life expectancy further places them at increased risk of delayed adverse health effects that may develop years or decades after exposure in early life to uranium or other chemical contaminants in drinking water.

Because of its radioactivity, concern has arisen about the possible carcinogenicity of uranium. However, the levels of uranium that have been observed to induce nephrotoxicity are much lower than those that increase risk of cancer, and uranium intake from contaminated water has not been associated with increased risk of human cancer ([@b11-ehp0115-001237], [@b12-ehp0115-001237]; [@b15-ehp0115-001237]; [@b28-ehp0115-001237]; [@b29-ehp0115-001237]). A recent study that examined a cluster of childhood leukemia cases in Fallon, Nevada, found that the town had levels of uranium above or greatly above the maximum contaminant level. However, the children in Fallon with leukemia did not have a higher exposure to uranium than children without leukemia ([@b40-ehp0115-001237]).

Although levels of arsenic, radium, and radon were elevated in the index family's water supply, none of these substances are known to have nephrotoxic effects.

In summary, this case series demonstrates the potential for significant residential exposure to naturally occurring uranium in groundwater. It underscores the hazards of consuming groundwater from untested private wells ([@b49-ehp0115-001237]). It confirms previous epidemiologic studies showing that chronic, low-level exposure to uranium in drinking water may result in mild injury to the proximal renal tubule ([@b29-ehp0115-001237]). It highlights the special sensitivity of young children to environmental exposures ([@b34-ehp0115-001237]). Public health organizations should take the unique exposures and the special vulnerability of children into consideration when setting standards for uranium and other chemical contaminants in drinking water.
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###### 

Well water uranium in homes, suburban development, northwestern Connecticut, October--November 2000.

  Water uranium                                        Case family (Home 1)   Home 2   Home 3   Home 4   Home 5   Home 6   Home 7   Home 8   Home 9   Home 10   Home 11
  ---------------------------------------------------- ---------------------- -------- -------- -------- -------- -------- -------- -------- -------- --------- ---------
  pCi/L                                                1049.00                41.00    0.19     12.50    7.50     12.20    7.50     469.00   14.70    32.00     19.00
  μg/L[a](#tfn2-ehp0115-001237){ref-type="table-fn"}   1165.56                45.56    0.21     13.89    8.33     13.56    8.33     521.11   16.33    35.56     21.11

Testing done by CT DOH Lab.

Mass calculated from activity measurements using EPA conversion factor of 0.9 pCi/μg.

###### 

Urine measurements of uranium, β2-microglobulin (β2-M), and creatinine.

  -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Subject   Age \[years (sex)\]   Test date   Uranium in 24 hr (μg/L)   Urine volume in 24 hr (L)   Uranium excretion (μg/24 hr)[a](#tfn4-ehp0115-001237){ref-type="table-fn"}   Uranium excretion (ng/mmol creatinine)   β2-M (μg/L)[b](#tfn5-ehp0115-001237){ref-type="table-fn"}   Creatinine (mmol/L)   β2-M excretion rate (μg β2-M/mmol creatinine)[c](#tfn6-ehp0115-001237){ref-type="table-fn"}
  --------- --------------------- ----------- ------------------------- --------------------------- ---------------------------------------------------------------------------- ---------------------------------------- ----------------------------------------------------------- --------------------- ---------------------------------------------------------------------------------------------
  1         3 (F)                 Oct 2000\   6.2                       0.4                         2.5                                                                          1,062                                    532\                                                        5.84\                 90.8\
                                  Jan 2001                                                                                                                                                                                267                                                         5.13                  52

  2         5 (M)                 Oct 2000\   4.9                       0.475                       2.3                                                                          690                                      100\                                                        7.1\                  14.1\
                                  Jan 2001                                                                                                                                                                                174                                                         9.08                  19.2

  3         7 (M)                 Oct 2000\   \< 1                      0.7                         \< 1                                                                         NA                                       140\                                                        7.4\                  18.9\
                                  Jan 2001                                                                                                                                                                                343                                                         12.24                 28

  4         9 (M)                 Oct 2000\   4.1                       0.5                         2.1                                                                          532                                      90\                                                         7.7\                  11.7\
                                  Jan 2001                                                                                                                                                                                89                                                          11.12                 8

  5         12 (M)                Oct 2000\   1.2                       1.4                         1.7                                                                          97                                       280\                                                        12.4\                 22.6\
                                  Jan 2001                                                                                                                                                                                167                                                         9.8                   17

  6         34 (M)                Oct 2000\   \< 1\                     0.85\                       \< 1\                                                                        NA                                       100                                                         18.5                  5.4
                                  Nov 2000    1.2                       1.1                         1.3                                                                                                                                                                                                     

  7         37 (F)                Oct 2000\   1.3\                      0.65\                       0.8\                                                                         92                                       130                                                         14.1                  9.2
                                  Nov 2000    1.1                       1.025                       1.1                                                                                                                                                                                                     
  -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Abbreviations: F, female; M, male; NA, cannot be calculated. Oct and Nov 2000 samples are 24-hr collections; Jan 2001 sample is a random sample. Conversion factor: 1,000 ng = 1 μg. β~2~-M excretion rate = urinary β-2-M:creatinine ratio.

Uranium reference level \< 1.0 μg/24 hours unexposed population.

β~2~-M reference level ≤120 μg/L (adults 21--57 years of age).

β~2~-M excretion rate reference level in children: \< 40 μg β~2~-M/g creatinine.

###### 

Urine analysis and electrolyte measurements of the five children (1--5).

  Characteristic                                          1          2          3          4          5
  ------------------------------------------------------- ---------- ---------- ---------- ---------- ----------
  Age \[years (sex)\]                                     3 (F)      5 (M)      7 (M)      9 (M)      12 (M)
  Test date                                               Jan 2001   Jan 2001   Jan 2001   Jan 2001   Jan 2001
  Serum \[HCO~3~^--^\] (mmol)                             21.9       23.0       24.4       28.1       27.7
  TRP (%)[a](#tfn7-ehp0115-001237){ref-type="table-fn"}   92         92         95         92         91
  PH                                                      6          7          6          7          6.5
  Specific gravity                                        1.015      1.025      1.020      1.025      1.020
  Glucose dip                                             Negative   Negative   Negative   Negative   Negative
  Protein dip                                             Negative   Negative   Negative   Negative   Negative

TRP (%) = tubular reabsorption of phosphate = \[1 -- (*U~p~×S~Cr~*)/(*S~p~* *×U~Cr~*)\] *×*100, where *U~p~*, *S~Cr~*, *S~p~*, and *U~Cr~* are urine phosphate, serum creatinine, serum phosphate, and urine creatinine concentrations, respectively. Normal values are \> 85%.

###### 

Uranium and β2-microglobulin analytic methods.

  Analysis                                                                                 Method
  ---------------------------------------------------------------------------------------- ----------------------------------------------------------------------------------
  Uranium in water (RSA Laboratories, CT)                                                  Ion exchange separation with alpha-spectrometry detection ([@b2-ehp0115-001237])
  Uranium and radium in water (Connecticut State Department of Public Health Laboratory)   Gas proportional analysis; EPA Method 908-0 ([@b46-ehp0115-001237])
  Uranium in urine (quest diagnostics sent out to Medtox Laboratories, St. Paul, MN)       Inductively coupled plasma/mass spectrometry
  β2-microglobulin in urine (quest diagnostics, Medtox Laboratories, St. Paul, MN)         Fixed rate time nephelometry
  Creatinine in urine (quest diagnostics, Medtox Laboratories, St. Paul, MN)               Spectrophotometry
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